Domperidone

多潘立酮

Report date: 2022/02/08 13:49:57
NME

Base Information

Drug NameDomperidone
Drug Alias NameMotilium吗丁啉
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsVomitingNauseaHeartburn +[13] 
Global Approved IndicationsVomitingNauseaGastrointestinal Diseases
Approved Indications in ChinaVomitingNausea
Original Approved Country/TerritoryJapan
Original Approved Date1982/09/01
Country/TerritoryBelgiumCanadaUnited States +[11] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesXian Janssen Pharmaceutical LtdKyowa Hakko Kirin Co LtdPharmacin Products Bv +[5] 
Inactive CompaniesJanssen-Cilag International NvYale UniversityUniversity Of Calgary +[5] 
Active IndicationsVomitingNauseaHeartburn +[8] 
Inactive IndicationsParkinson DiseaseMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Chronic Progressive +[5] 

Other Information

ATC CodeA03FA03
Related LinksN/A